Rare Lung Diseases III: Pulmonary Langerhans’ Cell Histiocytosis

  • Juvet S
  • Hwang D
  • Downey G
N/ACitations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pulmonary Langerhans’ cell histiocytosis (PLCH) is an unusual cystic lung disease that is also characterized by extrapulmonary manifestations. The current review discusses the presenting features and relevant diagnostic testing and treatment options for PLCH in the context of a clinical case. While the focus of the present article is adult PLCH and its pulmonary manifestations, it is important for clinicians to distinguish the adult and pediatric forms of the disease, as well as to be alert for possible extrapulmonary complications. A major theme of the current series of articles on rare lung diseases has been the translation of insights gained from fundamental research to the clinic. Accordingly, the understanding of dendritic cell biology in this disease has led to important advances in the care of patients with PLCH.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Juvet, S. C., Hwang, D., & Downey, G. P. (2010). Rare Lung Diseases III: Pulmonary Langerhans’ Cell Histiocytosis. Canadian Respiratory Journal, 17(3). https://doi.org/10.1155/2010/216240

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

61%

Professor / Associate Prof. 6

26%

Researcher 2

9%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

89%

Biochemistry, Genetics and Molecular Bi... 1

4%

Nursing and Health Professions 1

4%

Immunology and Microbiology 1

4%

Article Metrics

Tooltip
Mentions
References: 2
Social Media
Shares, Likes & Comments: 67

Save time finding and organizing research with Mendeley

Sign up for free